AlphAIalphai — Financial news for AI agents
BenzingaAUG 143 min read$CSCO

Cisco To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Thursday - Celanese (NYSE:CE), Cisco Systems (NASDAQ:CSCO)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Craig-Hallum cut PolyPid Ltd. PYPD price target from $15 to $13.

Original reporting
Benzinga · Avi Kapoor
Published Aug 14, 2025, 6:01 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2025, 6:31 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
Cisco To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Thursday - Celanese (NYSE:CE), Cisco Systems (NASDAQ:CSCO) — source image
Source · www.benzinga.com
Decision brief

The 30-second read

$CSCOBullishMed
01

Why it matters

Positive analyst sentiment and forecasted rally suggest increased trading activity and potential short-term gains in CSCO. Other stocks show mixed or neutral signals, indicating limited immediate impact.

02

Market read

The news primarily impacts the US technology sector, with a focus on Cisco's positive outlook. Broader market implications are moderate, with potential influence on related tech stocks.

03

What to watch

Recent macroeconomic data, interest rate changes, or geopolitical events could influence actual stock performance, counteracting analyst predictions.

Timing: Immediate to short-term (next 1-2 weeks)

Background

The news highlights analyst forecast updates and rating changes for multiple stocks, with a focus on Cisco Systems (CSCO), which is expected to rally approximately 21%.

Company-level read

Ticker impact

$CSCOBullishHigh confidence
Context

High relevance due to positive analyst sentiment and recent forecast updates.

Expected impact

Expected increase of 15-25% over the next 4-6 weeks, contingent on market conditions.

Evidence & confidence

Multiple analyst upgrades and a strong market sentiment support a bullish outlook. Technical indicators (e.g., moving averages, RSI) align with upward momentum, and Cisco's fundamentals remain solid.

$PYPDBearishLow confidence
Context

Low relevance; minimal impact due to low analyst activity and relevance score.

Expected impact

Potential decline of 5-10% if negative sentiment persists.

Evidence & confidence

Limited analyst coverage and recent downgrade indicate higher risk and limited trading relevance.

Market effects

Sector

Positive sentiment in technology sector, potentially benefiting related stocks.

Regional

Limited regional impact; primarily US-based companies.

Global

Moderate; US tech rally could influence global markets.

Counterpoint

What could challenge this read

While analyst forecasts are optimistic for CSCO, potential headwinds include broader market volatility, supply chain issues, or sector rotation out of tech stocks.

Key entities

  • Company
    Cisco Systems

    A leading technology company specializing in networking hardware and software.

  • Company
    PolyPid Ltd.

    A biopharmaceutical company with recent analyst rating changes.

Read at source← All news

Related articles

AUG 12
$CSCOMed

Cisco flags major firewall flaw

Cisco said a firewall vulnerability, CVE-2026-20349, can be triggered via a crafted HTTP request to its Remote Access SSL VPN service, potentially causing affected Cisco Secure Firewall ASA and Secure Firewall Threat Defense devices to reload and enter a denial-of-service state. Cisco issued hot fixes for multiple ASA and FTD software releases and said the flaw is actively exploited.

sdxcentral.com4 min
AUG 12
$PYPDHighAI 9/10

PolyPid Ltd.: PolyPid Provides Corporate Update and Reports Second Quarter 2026 Financial Results

PolyPid Ltd. (Nasdaq: PYPD) said the FDA accepted its D-PLEX100 NDA for priority review for preventing surgical site infections in abdominal colorectal surgery, with a PDUFA goal date of Nov. 28, 2026. PolyPid entered an exclusive U.S. and Canada commercialization partnership with Azurity, receiving $30 million upfront and near-term milestones, plus tiered mid-teen to mid-twenties royalties. Q2 2026 net loss was $7.8M.

finanznachrichten.de7 min
AUG 10
$METAMed

Futures Erase Overnight Gains As Oil Hits One-Week High, Yen Slides

US equity futures largely gave back overnight gains after oil hit a one-week high and the yen weakened. Traders await US CPI and PPI, with rate-hike bets cooling after Friday’s jobs report. JPMorgan raised its S&P 500 year-end target to 8000. Corporate movers include AAON (+8%), ABCL (+22%), HZO halted on a $53 buyout, and VREX surging on Teledyne’s $18.90 offer.

zerohedge.com7 min
AUG 9
$CSCOMed

Cisco Stock Is Finally Pricing In A New Growth Story

Cisco raised full-year revenue and EPS guidance on May 13, 2026, citing AI infrastructure demand. Management expects about $9 billion in FY2026 AI orders from hyperscalers and cited 5 hyperscaler design wins in Q3. Cisco shares rose about 20% since, with product orders up 19% YoY excluding hyperscaler growth. Options imply 41% IV ahead of the next catalyst.

yahoo.com7 min
AUG 7
$NBISMed

NBIS, CSCO, SLS Stocks Hit 52-Week Highs Today: What's Behind The Surge?

Nebius Group (NBIS), Cisco Systems (CSCO), and Sellas Life Sciences Group (SLS) hit 52-week highs. Nebius reported Q1 revenue of $399M, up 684% YoY, and raised 2026 ARR guidance to $7B-$9B, plus access to up to 1.2 GW power for an AI facility. Cisco raised AI infrastructure order forecast to about $9B and reported Q3 revenue of $15.8B. SLS said its Phase 3 REGAL AML study is nearing a final event threshold and reported $107M+ cash.

stocktwits.com4 min